Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Atheroembolic disease--a frequently missed diagnosis: results of a 12-year matched-pair autopsy study.

Fries C, Roos M, Gaspert A, Vogt P, Salomon F, Wüthrich RP, Vavricka SR, Fehr T.

Medicine (Baltimore). 2010 Mar;89(2):126-32. doi: 10.1097/MD.0b013e3181d5eb39.

2.

[Immunoallergic interstitial nephritis vs. cholesterol atheroembolism. Differentiating characteristics].

Espejo B, Herrero JC, Torres A, Martínez A, Gutiérrez E, Morales E, González E, Bueno B, Valentín MO, Praga M.

Nefrologia. 2003;23(2):125-30. Review. Spanish.

3.

Cholesterol crystal embolism: A recognizable cause of renal disease.

Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E, Maiorca R.

Am J Kidney Dis. 2000 Dec;36(6):1089-109. Review.

PMID:
11096032
4.

Cholesterol crystal embolization in the Netherlands.

Moolenaar W, Lamers CB.

Arch Intern Med. 1996 Mar 25;156(6):653-7.

PMID:
8629877
5.

[Cholesterol embolism: a diagnostic puzzle and a therapeutic dilemma].

Balestra B.

Schweiz Rundsch Med Prax. 1994 May 10;83(19):566-9. German.

PMID:
8202655
6.

A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants.

Heininger U, Kleemann WJ, Cherry JD; Sudden Infant Death Syndrome Study Group..

Pediatrics. 2004 Jul;114(1):e9-15.

PMID:
15231967
7.

Nephrotic-range proteinuria in renal atheroembolic disease: report of four cases.

Haqqie SS, Urizar RE, Singh J.

Am J Kidney Dis. 1996 Oct;28(4):493-501.

PMID:
8840937
8.
9.

Pediatric stroke among Hong Kong Chinese subjects.

Chung B, Wong V.

Pediatrics. 2004 Aug;114(2):e206-12.

PMID:
15286258
11.

NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).

National Toxicology Program ..

Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.

12.

Cholesterol embolism: still an unrecognized entity with a high mortality rate.

Jucgla A, Moreso F, Muniesa C, Moreno A, Vidaller A.

J Am Acad Dermatol. 2006 Nov;55(5):786-93. Epub 2006 Jun 27.

PMID:
17052483
13.

Redefining the incidence of clinically detectable atheroembolism.

Mayo RR, Swartz RD.

Am J Med. 1996 May;100(5):524-9.

PMID:
8644764
14.

[Cholesterol embolism disease: study of 16 cases].

Ribera Pibernat M, Bigatà Viscasillas X, Fuentes González MJ, Bielsa Marsol I, Ferrándiz Foraster C.

Rev Clin Esp. 2000 Dec;200(12):659-63. Spanish.

PMID:
11234471
15.

The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.

Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A; Cholesterol Embolism Study(CHEST) Investigators..

J Am Coll Cardiol. 2003 Jul 16;42(2):211-6.

16.

Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area.

Kaczynski J, Hansson G, Wallerstedt S.

Hepatogastroenterology. 2005 Nov-Dec;52(66):1798-802.

PMID:
16334780
17.
18.
19.

The natural history of Alzheimer's disease: a brain bank study.

Jost BC, Grossberg GT.

J Am Geriatr Soc. 1995 Nov;43(11):1248-55.

PMID:
7594159
20.

Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure.

Scolari F, Bracchi M, Valzorio B, Movilli E, Costantino E, Savoldi S, Zorat S, Bonardelli S, Tardanico R, Maiorca R.

Nephrol Dial Transplant. 1996 Aug;11(8):1607-12.

PMID:
8856220

Supplemental Content

Support Center